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IN RECENT YEARS, the possibility of a deadly influenza pandemic, the episode
of severe acute respiratory syndrome (SARS), concerns over bioterrorism,
the HIV/AIDS epidemic, and no doubt other events have increased the im-
portance with which global public health is viewed. Even without an “event,”
though, health has a strong claim on our attention, for humanitarian rea-
sons if none other. The World Bank’s 1993 World Development Report, a flag-
ship document in the field of health and development, identified a mini-
mum care package that would cost a mere US$12 per capita (in 1990 terms)
to deliver. The World Health Organization (WHO) estimates that the cost of
an essential health care package in low-income countries is $12 per capita,
and in middle-income countries $22 per capita. The comparison between
the misery caused by poor health in the developing world and the appar-
ently trivial sums required to improve it could not be more striking.
But is the global community willing to act? The international assis-
tance required to finance adequate levels of health in poor countries was
estimated by the WHO Commission on Macroeconomics and Health (2001)
to be $27 billion in 2007: $22 billion for in-country programs, $3 billion for
research and development targeted at diseases of the poor, and $2 billion in
classic global public goods such as collection and analysis of epidemiologi-
cal data and surveillance of infectious disease. This sum may be compared
to actual spending of only about $6 billion per year in 2001. The United
Nations High Level Panel on Financing for Development, the so-called Zedillo
Commission, estimated that an extra US$7–10 billion per year in resources
is required at a minimum to fight communicable diseases alone (United Na-
tions 2001).
This enormous gap between needs and current spending suggests that,
however innovative the funding strategies devised, Zedillo- and WHO-size
goals are unlikely to be met in anything approaching their entirety. When
needs vastly outstrip resources, priority setting is crucial. Aggregate trends
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in official development assistance for health, AIDS, and population have
been documented (OECD 2001: 139–150; Development Assistance Com-
mittee-UNAIDS 2004 for HIV/AIDS), and the question of how disease pri-
orities ought to be set has received a great deal of attention. Apart from anal-
ysis by Shiffman (2004) on infectious disease, however, little work has been
done on how they actually are set.
This article consists of three parts. The first examines international as-
sistance for health, AIDS, and population for two years, 1993 and 2003.
This period is roughly framed by two landmark events in international health
policy: publication in 1993 of the aforementioned World Development Report,
subtitled Investing in Health; and publication at the end of 2001 of the Re-
port of the WHO Commission on Macroeconomics and Health. During this
decade, health emerged as a key strategic sector in development, and links
between health and poverty were increasingly recognized.
The second part, building on the approach that Shiffman has applied
to infectious disease, compares development assistance for health, AIDS,
and population in various intervention categories to the burden of disease
in the corresponding disease categories. The question is how closely devel-
opment assistance allocations match the burden of disease and, where they
do not, what the explanation might be.
The third part summarizes an ad hoc but innovative attempt to assess
stated health priorities in poor countries and the extent to which patterns
of official development assistance conform to them. While concerns have
long been expressed that international assistance may not reflect priorities
in recipient countries (Maizels and Nissanke 1984), this concern has lately
been heightened as the global public good perspective on health is increas-
ingly used to justify support for spending (Sagasti and Bezanson 2001;
Sandler and Arce 2001). It also reflects the conviction, expressed, for ex-
ample, at the March 2005 High Level Forum on Aid Effectiveness in Paris,
that aid is effective only if it is aligned with country priorities.
Trends in aggregate development assistance and
in assistance for health and population
In view of the gap between resources and needs, a range of innovative ap-
proaches to health financing has been proposed (Atkinson 2003; Reisen
2004; Stansfield et al. 2001). Innovative public–private partnerships are un-
derway in the form of the Global Fund to Fight AIDS, Tuberculosis and
Malaria; the International AIDS Vaccine Initiative; the US President’s Emer-
gency Program for AIDS Relief; the Global Alliance for Vaccines and Immu-
nization; Stop TB; and Roll Back Malaria. However, the bulk of resources
for these and other initiatives still comes from the traditional source: do-
nor-country governments as represented in the Development Assistance
Committee and, to a lesser extent, multilateral institutions such as the World
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Bank.1 The primary vehicle for in-country projects remains official devel-
opment assistance; therefore, trends in such assistance should be a reason-
able measure of global priorities.
Aggregate development assistance
The standard source for data on official development assistance is the Creditor
Reporter System database maintained by the Development Assistance Com-
mittee. The data employed in this article were compiled by aggregating, for
1993 and 2003 (the most recent year available), the finest-grained infor-
mation available in the database.2 In an effort to be comprehensive, I in-
clude all donors, all recipients, and all types of assistance, including loans
(fairly few and far between in assistance for health, AIDS, and population).
The limitations of the Creditor Reporter System database are well
known. The Organization for Economic Co-operation and Development has
estimated that it is only about 75 to 80 percent complete for the 1990s (OECD
2001: 140). Data are for commitments, not actual disbursements, which
may be significantly lower. Other problems include the fact that classifica-
tion in the database is all-or-nothing: for example, a reproductive health
and family planning project that includes a substantial HIV/AIDS compo-
nent will not appear in the HIV/AIDS category. The database does not cover
private foundations and nongovernmental organizations (NGOs) and is in-
complete for UN agencies and the European Commission through its Euro-
pean Development Fund. Nevertheless, the Creditor Reporting System data
continue to be widely used to identify major trends in and characteristics of
development assistance.
In the Development Assistance Committee classification system, health
activities fall under the category “Social infrastructure and services.” They
are further subdivided into “General health” (health policy and administra-
tive management, medical education/training, medical research, and medi-
cal services) and “Basic health” (basic health care, basic health infrastruc-
ture, basic nutrition, infectious disease control, health education, and health
personnel development). Population activities encompass population policy
and administrative management, reproductive health care, family planning,
sexually transmitted disease (STD) control including HIV/AIDS, and per-
sonnel development for population and reproductive health. In fact, HIV/
AIDS accounts for almost all assistance for STD control.
Areas of development assistance not directly related to health, AIDS,
and population are other social infrastructure and services (aid to the edu-
cation sector, water and sanitation projects, and projects aimed at encour-
aging good governance and the development of civil society), economic in-
frastructure (banking, transport, etc.), sector aid (agriculture, industry, etc.),
commodity and general programmatic assistance (chiefly nonemergency food
aid, structural adjustment funds, and general budget/balance-of-payments
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support), multisector assistance (women in development, environment, and
rural development), and actions related to debt (debt forgiveness, resched-
uling, etc.). Some of these, such as water and sanitation and nutrition, clearly
have health benefits; indeed, one could argue that any assistance that ac-
celerates development is bound to benefit health. In this article, however, I
consider only interventions explicitly assigned to the health category.
Development assistance for health, AIDS, and
population, 1993 and 2003
As shown in Table 1, official development assistance for health, AIDS, and
population is estimated to have more than doubled, from $3,107 million in
1993 to $6,719 million in 2003 (these and all other figures given here are
in 2002 prices). The implied growth rate of 8.0 percent per annum con-
firms the rapid expansion in this sector. Total development assistance grew
more slowly, by 5.9 percent per annum over the period, so the share de-
voted to health, AIDS, and population increased from 5.5 percent to 6.7
percent of total development assistance. While the share of assistance de-
voted to health is only one measure of priority, this is evidence that in-
creasing attention to the health sector in development is being backed up
with development assistance resources. Many of these resources, however,
were devoted to the unforeseen HIV/AIDS crisis. In 1993, HIV/AIDS repre-
sented an insignificant 0.1 percent of total development assistance; in 2003,
it represented 1.8 percent—an increase at a rate of 36.7 percent per an-
num. Health and population minus HIV/AIDS actually lost share in total
TABLE 1 Official development assistance for health, AIDS, and
population, US$ million (2002 prices)
Growth rate
(percent per
1993 2003 annum)
Health, AIDS, and population 3,107 6,719 8.0
AIDS 77 1,754 36.7
Health and population 3,030 4,965 5.1
Total development assistance 56,451 99,892 5.9
Health, AIDS, and population share in
total development assistance (percent) 5.5 6.7
AIDS share in total development
assistance (percent) 0.1 1.8
Health and population share in total
development assistance (percent) 5.4 5.0
SOURCE: Creditor Reporting System.
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development assistance over the decade, from 5.4 percent in 1993 to 5.0
percent in 2003.
Table 2 focuses on those health, AIDS, and population intervention
subsectors most broadly identified as “pro-poor.” This list consists of “Basic
health” as defined by the Development Assistance Committee, plus repro-
ductive health and family planning and STDs including HIV/AIDS.
Taken together, the pro-poor subsectors experienced an increase in
share between 1993 and 2003, from 3.3 percent to 4.6 percent of total offi-
cial development assistance and from 59.7 percent to 68.1 percent of devel-
opment assistance for health, AIDS, and population. Once the category HIV/
AIDS is removed, however, the share of the remaining pro-poor subsectors
declined from 3.1 percent to 2.8 percent of total development assistance
and from 57.2 percent to 42.0 percent of assistance for health, AIDS, and
population.3 Removing HIV/AIDS from the calculations reveals both that
health lost share of total development assistance and that assistance for
health, AIDS, and population aid became less pro-poor over the decade.
The only one of the non-HIV/AIDS subsectors in Table 2 that experi-
enced an increase in share was infectious disease control, rising from 0.2
percent to 0.7 percent of total official development assistance and from 3.5
percent to 10.2 percent of assistance for health, AIDS, and population. Be-
cause infectious disease control is a classic public good, this increase in share
may be evidence of the growing importance of the global public good per-
TABLE 2 Health, AIDS, and population intervention subsector shares in
official development assistance, 1993 and 2003
Share of intervention subsector in
Health, AIDS,
and population
All development development
assistance assistance
Intervention subsector 1993 2003 1993 2003
Basic health care and infrastructure 0.8 0.8 14.1 12.2
Health education and personnel
development 0.3 0.1 6.2 0.8
Basic nutrition 0.6 0.2 10.9 2.8
Infectious disease control (excl. HIV/AIDS) 0.2 0.7 3.5 10.2
Reproductive health and family planning 1.2 1.1 22.5 16.0
Total, pro-poor subsectors excl. STDS
and HIV/AIDS 3.1 2.8 57.2 42.0
STDs incl. HIV/AIDS 0.1 1.8 2.5 26.1
Grand total, pro-poor health, AIDS, and
population subsectors 3.3 4.6 59.7 68.1
SOURCE: Creditor Reporting System.
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spective on health. However, many other factors, such as growing realiza-
tion of links between infectious disease and development and increased ap-
preciation of cost-effective responses such as anti-mosquito bed nets, could
also be explanations.
While disaggregated data are not shown in Table 2, similar observa-
tions can be made for countries classified as “least-income” by the Develop-
ment Assistance Committee. In these countries, development assistance for
health, AIDS, and population increased from 5.9 percent to 7.2 percent of
total assistance; but once HIV/AIDS is removed, health and population ex-
perienced a decline in share, from 5.6 percent to 4.6 percent. Development
assistance in the pro-poor, non-HIV/AIDS subsectors declined from 3.2 per-
cent to 2.4 percent of total development assistance and from 54.8 percent
to 36.3 percent of assistance for health, AIDS, and population. The share of
assistance for HIV/AIDS increased from 0.2 percent to 2.6 percent of total
development assistance and from 4.3 percent to 36.3 percent of assistance
for health, AIDS, and population. Thus, while the pro-poor subsectors taken
as a whole experienced an increase from 3.2 percent to 5.0 percent of total
official development assistance and from 54.8 percent to 70.0 percent of
health, AIDS, and population assistance, it was HIV/AIDS that accounted
for this increase. Infectious disease control again stands out, however, as a
subsector that gained share, from 0.2 percent to 0.4 percent of total devel-
opment assistance and from 2.7 percent to 5.0 percent of assistance for
health, AIDS, and population.
To summarize, then, over a decade during which health became a major
component of development strategy and links between health and poverty
were increasingly recognized, health and population apart from HIV/AIDS
actually lost share in total official development assistance. Even more strik-
ing, with the exception of HIV/AIDS, subsectors of health, AIDS, and popu-
lation generally considered pro-poor also lost weight. These trends are ob-
served not only for low- and middle-income countries as a whole, but also
for the subset of least-income countries.
Health and population assistance and
the burden of disease
Priority setting is particularly crucial when available resources fall far short of
needs. A great deal of normative work has been devoted to how interna-
tional disease control priorities should be set. The flagship project in this area,
the WHO–World Bank–US National Institutes of Health Disease Control Pri-
orities Project, emphasizes the burden of disease as measured in disability-
adjusted life years. The Global Forum for Health Research (2004) has pro-
posed a framework in which health research and development priorities should
be set according to reduction in the burden of disease per dollar spent, the
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determinants of the burden of disease, impact on equity, the scientific prob-
ability of success, feasibility, and contribution to capacity building.
Much less attention has been given to the equally important question
of how global disease priorities are actually set. An exception to this is ongo-
ing work by Shiffman (2004), who examines donor priorities in the area of
infectious disease and concludes that considerations include not only the bur-
den of disease, but also the speed of spread, the ability of poor countries to
cope on their own, the existence of cost-effective interventions, the charac-
teristics of the victims of disease, the prevalence and risk of infection in do-
nor countries, and other political and economic factors. This section extends
the work of Shiffman to cover all forms of disease, not just infectious disease.
Following him, I compare data on health interventions from the Creditor Re-
porter System (CRS) database with WHO data on the burden of disease. I
conclude that the burden of disease as conventionally measured can explain
only part of health priorities as revealed by patterns of assistance.
The burden of disease has many dimensions: years of life lost due to
premature death, physical suffering due to pain and disability, economic
opportunity costs, social stigma, and so on. No single measure can capture
all these aspects; however, health policymakers have generally accepted dis-
ability-adjusted life years (DALYs) lost to given disease categories as the
best comprehensive measure of the burden of disease. One DALY repre-
sents a single lost year of healthy life, and the sum of DALYs lost to all
causes can be interpreted as the gap between the actual health situation
and an ideal world in which everyone lives disease- and disability-free to
an advanced age (age 80 for men and 82.5 for women, according to the
convention used by WHO). DALYs lost to a given disease category divided
by total DALYs lost is a measure of the importance of that disease category
relative to all diseases combined.4
Column 1 in Table 3 contains the estimated burden of disease (in
DALYs) by major disease category for the year 2001. Four of these disease
categories are directly comparable to development assistance intervention
subsectors in the database of the Creditor Reporter System. These disease
categories are
—Infectious diseases excluding HIV/AIDS and other STDs. This cat-
egory, accounting for 23.6 percent of the total burden of disease in 2001,
corresponds to “infectious disease control” in the CRS database.
—STDs including HIV/AIDS, accounting for 5.8 percent of the total bur-
den of disease, is directly comparable to the same category in the CRS data-
base. Readers are sometimes surprised by the modest share of DALYs ac-
counted for by HIV/AIDS, but this is the result of the very large number of
life years lost to other conditions such as malaria and respiratory infections.
—Maternal health and perinatal conditions; this category corresponds
to “reproductive health care” and, because of the important role of child
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spacing, “family planning” in the CRS. It is estimated to account for 8.3
percent of the total burden of disease.
—Nutritional deficiencies, which correspond to “basic nutrition” in the
CRS database. These were estimated to account for 2.8 percent of the total
burden of disease.
Noncommunicable diseases are completely absent from the category
of directly attributable interventions shown in Column 3 of Table 3, as are
injuries, because interventions to address these areas are not perceived to
be pro-poor. 5 Yet cardiovascular conditions, cancer, mental illness, diabe-
tes, and other noncommunicable conditions are accounting for a fast-rising
share of mortality and morbidity in developing countries. This trend will
become pronounced as populations age, as income levels rise, and as recent
increases in tobacco use make their presence felt.
Looking only at directly attributable interventions is misleading because
general interventions (“policy administration and management,” “basic health
care,” “basic health infrastructure,” “medical education,” etc.), amounting to
45.1 percent of all development assistance for health, AIDS, and population,
also contribute to reducing the burden of disease. How to distribute general
TABLE 3 Burden of disease in low- and middle-income countries and
shares of development assistance, early 2000s
Share of development
assistance for health, AIDS,
and population, 2003
Directly
attributable
interventions
plus imputed
general
DALYs Share of Directly assistance
lost, total attributable for health,
2001 burden inter- AIDS, and
Disease category (000s) of disease ventions population
Communicable diseases, maternal
health, perinatal conditions, and
nutritional deficiencies 552,639 39.8 54.9 72.9
Infectious diseases
(excluding STDs and HIV/AIDS) 327,407 23.6 10.2 20.8
STDs and HIV/AIDS 80,173 5.8 25.9 28.5
Maternal health and perinatal
conditions 115,494 8.3 16.0 19.8
Nutritional deficiencies 29,564 2.1 2.8 3.8
Noncommunicable diseases 678,842 48.9 0.0 22.1
Injuries 155,945 11.2 0.0 5.1
Total burden of disease 1,387,426 100.0 54.9 100.0
SOURCES: DALYs, Disease Control Priorities Project (see endnote 4); development assistance, Creditor Reporting System.
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health expenditure across disease categories is a contentious issue. Table 3
follows one rule appealing in its simplicity, namely imputing general devel-
opment assistance for health, AIDS, and population across burden-of-disease
categories using shares of the total burden of disease (Column 2). For ex-
ample, of the 45.1 percent of such assistance that cannot be directly identi-
fied by disease intervention, I impute 5.8 percent to STDs including HIV/AIDS,
8.3 percent to maternal and reproductive health, and so on.
The most striking fact revealed by Table 3 is that HIV/AIDS is being
allocated a much higher share of official development assistance than can
be explained by its share in the burden of disease. STDs including HIV/AIDS
accounted for 5.8 percent of the burden of disease in 2001, but for 25.9
percent of assistance for health, AIDS, and population in 2003, or 28.5 per-
cent if my approach to imputation of general health assistance is accepted.
Maternal and perinatal health, accounting for 8.3 percent of the burden of
disease but for 16.0 percent of directly attributable assistance for health,
population, and AIDS and 19.8 percent if general assistance is imputed, also
received a share of resources higher than its share in the burden of disease.
This is so despite the significant reduction in share during the 1990s that
may be observed in Table 2. If only direct interventions are counted, infec-
tious diseases apart from HIV/AIDS received far less attention than would
be warranted on the basis of their share in the burden of disease: 10.2 per-
cent of development assistance as opposed to 23.6 percent of the burden of
disease. However, if general assistance is imputed, this anomaly is resolved,
as infectious diseases excluding HIV/AIDS are estimated to account for 20.8
percent of assistance for health, AIDS, and population, not far out of line
with their share in the burden of disease. Noncommunicable diseases and
injuries are estimated to receive far less assistance than would be justified
by their contribution to the burden of disease.
The data in Table 3 are plotted in Figure 1. The 45-degree line repre-
sents the locus along which each disease condition receives the same share
of official development assistance as its share in the burden of disease. The
discussion above has in effect compared the data points in Figure 1 with
the 45-degree line. But we know, from Shiffman’s work on infectious dis-
eases, that shares of development assistance are decided on the basis of fac-
tors in addition to the burden of disease. Therefore, it is unreasonable to
expect the data points in Figure 1 to rest on the 45-degree line. For this
reason, I also draw a least-squares trend line through the data points. Sta-
tistical inference, let alone hypothesis testing, is not possible with so few
data points, but the trend line is still useful to give an idea of the average
relationship between the burden of disease as expressed in disability-ad-
justed life years and development assistance. HIV/AIDS, in particular, and
to lesser extent maternal and reproductive health, stand out as interven-
tion sectors that receive relatively generous allocations of assistance; nutri-
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tion and injuries appear as sectors that receive far less support than might
be expected.6
It may be argued that the least-squares line in Figure 1 is essentially
meaningless and so, therefore, is lying above or below it. In this case, we
might look simply at development assistance per disability-adjusted life year.
These data, shown in Table 4, reveal that whether or not general assistance
is imputed, HIV/AIDS receives far more dollars per DALY than any other
cause. Other infectious diseases, even when assigned a share of general as-
sistance commensurate with their large share of the burden of disease, re-
ceive a low level of assistance per DALY. By this criterion, the rising share
of infectious diseases in development assistance discussed in the previous
section appears to be well founded.
The main conclusion here is that health priorities as revealed by pat-
terns of development assistance differ markedly from the priorities that might
be predicted based on the burden of disease as measured in disability-ad-
justed life years. This conclusion broadens, to all disease categories,
Shiffman’s conclusion that infectious disease control priorities reflect many
factors other than the burden of disease alone.
HIV/AIDS receives an allocation of resources that is very generous com-
pared to its contribution to the total burden of disease. Yet this should not
come as a surprise. HIV/AIDS advocacy groups have been very effective.
SOURCES: DALYs, Disease Control Priorities Project (see endnote 4); development assistance, Creditor Reporting
System.
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The virus is spreading rapidly in many parts of the world, and current aid
allocations may reflect the conviction that, if not addressed now, the epi-
demic will be even worse in the future. The fear factor, the concern in do-
nor countries that the epidemic may affect their own populations if not
controlled elsewhere, cannot be ignored. In those countries that are most
severely affected, governments are entirely unable to cope with the conse-
quences of the epidemic. If uncontrolled, the epidemic has the potential to
undermine all health activities in some countries—indeed, all development
(Roberts 2003: 80–81). Thus, based largely on the availability of cost-effec-
tive means of HIV/AIDS prevention, the Copenhagen Consensus of econo-
mists recently rated slowing the spread of HIV/AIDS as the highest-priority
intervention for sustainable development (Lomborg 2004).
The special status given to HIV/AIDS has been made explicit by the
WHO Commission on Macroeconomics and Health, which in its Key Find-
ings termed the epidemic a “distinct and unparalleled catastrophe” requir-
ing “special consideration.” This view has been bolstered by the joint World
Bank–International Monetary Fund Development Committee (World Bank
2003: 9–10), which in a survey of global public goods identified HIV/AIDS
control as an area “especially” in need of attention and action.
A word is in order on disease categories apart from HIV/AIDS. Mater-
nal and reproductive health interventions are also attractive to donors for a
number of reasons: they are typically highly cost-effective; maternal and
reproductive health is of concern to a group widely perceived as vulnerable
(women, children, and adolescents); and an effective global advocacy com-
munity is in place. Poor nutrition, however, also disproportionately affects
children (and women), there are cost-effective interventions, and recent
work suggests that poor nutrition is enormously important if attention is
TABLE 4 Level of development assistance in 2003 per disability-adjusted
life year (US$, 2002 prices)
Development
assistance per
Development DALY (including
assistance per imputed general
DALY (directly assistance for
attributable inter- health, AIDS,
ventions only) and population)
Infectious disease (excl. STDs and HIV/AIDS) 2.09 4.27
STDs and HIV/AIDS 21.88 24.06
Maternal and perinatal conditions 9.29 11.46
Nutritional deficiencies 6.30 8.45
Noncommunicable disease 0.00 2.18
Injuries 0.00 2.17
SOURCE: DALYs, Disease Control Priorities Project (see endnote 4); development assistance, Creditor Reporting
System.
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given to its role as a co-factor in infectious disease prevention (Mason et al.
2003). Yet this category receives little support.
Does development assistance for health and
population reflect the priorities of poor countries?
The institutional context
The “Monterrey Consensus,” which now forms the basis for all develop-
ment assistance, rests on three pillars: “country ownership,” a comprehen-
sive and long-term approach, and partnership (World Bank 2003: 2). The
Monterrey Consensus provides the framework within which to pursue the
Millennium Development Goals adopted by 189 states.7 Developed coun-
tries and the development agencies will, in return for poor countries’ ef-
forts to attain the Millennium Development Goals, take primary responsi-
bility to establish a global partnership for development.
The Millennium Development Goals emerged from widespread dissat-
isfaction with the effectiveness of aid and reflected insistence on a “results
focus,” especially improved monitoring and evaluation (Devaradjan et al.
2002: 2). The cornerstone of the process for achieving the goals is the elabo-
ration, in all low-income countries, of a Poverty Reduction Strategy Paper
(World Bank nd: 7 and 8; World Bank 2002: 5); this process, in turn, is
meant to encourage countries to adopt a long-term vision that takes pov-
erty issues explicitly into account and reflects the views of all stakeholders.
Poverty-reduction strategies are meant to be country-driven (“ownership”
again), results-oriented, and participatory, that is, reflect input of civil soci-
ety and the private sector (Christiansen and Hovland 2003: 3). Countries
are meant to prioritize the Millennium Development Goals in accordance
with their long-term vision of development needs. Donors, as evidenced by
the March 2005 Paris Declaration on Aid Effectiveness, are committed to
“aligning” their assistance with country priorities.
Poor countries’ health priorities and
development assistance
There is no clear-cut way to quantitatively measure government health pri-
orities in poor countries. However, the same lack of information is no longer
a constraint when it comes to qualitative indicators of government health
priorities. Systematic evidence on the role of health in countries’ poverty-
reduction strategy papers is now available in a WHO database.8 This data-
base contains analytical findings on how health and poverty issues were
dealt with in 36 poverty-reduction strategies drafted between 2000 and 2003.
As described in detail elsewhere (MacKellar 2005), I summarized in-
formation available in the WHO database for three disease categories: in-
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fectious diseases excluding HIV/AIDS, HIV/AIDS, and maternal and repro-
ductive health. To roughly quantify the degree of government priority at-
tached to each area, I selected three criteria:
—Is the disease category explicitly identified in the country’s poverty-
reduction strategy?
—Are proposed interventions targeted at the poor (or, in the case of
HIV/AIDS, at vulnerable populations)?
—Is the strategy explicitly linked to the relevant Millennium Devel-
opment Goals?
If the answer to the question was “Yes,” I assigned a score of 1, if “No,”
a score of 0; summing across the three criteria, I arrived at an index of dis-
ease-category prioritization that runs from 0 to 3.
The logic behind the index is simple. Most countries, for instance, iden-
tified infectious disease as an area of concern, that is, most countries scored
1 on the first criterion. It stands to reason, however, that if a country truly
ascribed a high priority to infectious disease control in its long-run devel-
opment strategy, it would take the subsequent steps of targeting proposed
interventions toward the poor and linking its intervention strategy to the
relevant Millennium Development Goals.
Figures 2 to 7 are scatter plots of the share of three intervention
subsectors in total official development assistance and in health, AIDS, and
population assistance against the disease-category prioritization score. Noth-
ing in these charts shows evidence that recipient-country disease priorities
as expressed in the poverty-reduction strategies strongly affect either how
much of total development assistance is devoted to the corresponding in-
tervention subsector or how much of health, AIDS, and population assis-
tance is devoted to it. Countries that do not prioritize infectious disease are
just as likely to have received a high share of total and health, AIDS, and
population assistance dedicated to infectious disease control as countries
prioritizing the disease category. A number of countries that assigned no
priority to HIV/AIDS received, as is sensible, little assistance in that area.
However, some countries that satisfied all three criteria in the area of HIV/
AIDS received no more assistance in this area, proportionally speaking, than
countries assigning less priority to the disease. The same observation holds
for maternal and reproductive health.
These negative results are open to three interpretations. The first, predi-
cated on the assumption that my disease-category prioritization scores ac-
curately measure country priorities, is that donors do not take these priori-
ties into account when allocating development assistance.
The second interpretation is that the ad hoc index I have calculated is
unsatisfactory, that is, the disease-category prioritization scores are mean-
ingless and their representation in Figures 2–7 is best ignored.
A third interpretation is that the scores simply measure how well coun-
tries followed the guidelines for devising poverty-reduction strategies. In other
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words, the degree to which a country explicitly targeted strategies toward
the poor and linked proposed interventions to the relevant Millennium De-
velopment Goals may reflect not priorities per se, but whether the country
was able to produce a strategy that conformed to international standards.
In the third interpretation, donor countries seem to be more willing to
allocate resources to general health policy, administration, and management,
leaving it to recipient-country governments to make allocation decisions
across disease categories. After all, the move from project-based approaches
to sector-wide support is a vital aspect of country “ownership,” and the main
constraint to ownership is generally held to be country capacity. In Figures
8 and 9, I plot general health policy, administration, and management sup-
port against the average of the infectious disease, HIV/AIDS, and maternal
and reproductive health prioritization scores described above. My hypoth-
esis is that the average prioritization score serves as a proxy for country
capacity. There is some evidence in favor of this interpretation: most coun-
tries receiving a high share of development assistance in the form of gen-
eral support scored at least 2 on the average index. The evidence is hardly
compelling, however; some countries that scored high received relatively
small amounts of general health-sector assistance; some that scored low re-
ceived relatively large amounts.
The evidence presented in this section is ambiguous. This in itself is cause
for concern: however imperfect the index, one would expect to see at least
some evidence of a relationship between the way a disease category is treated
in the country strategy and the allocation of development assistance. It ap-
pears that a hypothetical advisor preparing for a country mission or a new
program officer in an international development organization would not be
able to infer with any confidence, from a reading of a country’s poverty-re-
duction strategy, how development assistance for health was being allocated.
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This suggests room for improvement in the process of preparing poverty-re-
duction strategies, in the allocation of official development assistance, or both.
Conclusions
The gap between needs and resources in global health development is enor-
mous, and, as a result, so is the importance of priority setting. Three ques-
tions of relevance to policymakers as they address this challenge are: What
are the recent trends in development assistance for the health sector, and
what do they tell us about overall priorities in health? What factors explain
priorities within the health sector? And how closely do observed develop-
ment assistance priorities correspond to the health priorities expressed by
policymakers in poor countries? In this article I have presented findings
related to these questions.
The short answer to the first question is that HIV/AIDS is the priority.
It accounts for the increased share of health in total official development
assistance over the last decade. If HIV/AIDS is excluded from the calcula-
tion, health has actually declined as a share of development assistance, from
5.4 percent in 1993 to 5.0 percent in 2003. Within the health, AIDS, and
population sector, apart from HIV/AIDS only infectious disease control has
seen an increased share of resources. It is possible that the rising share of
infectious disease control, a classic public good, reflects growing reliance on
the global public good rationale for international assistance, but other ex-
planations cannot be excluded. Basic health care and infrastructure, health
education and personnel development, reproductive health and family plan-
ning, and basic nutrition—all pro-poor interventions—have experienced
declining shares. Taken together, pro-poor health interventions apart from
HIV/AIDS have seen their share of health assistance drop from 57.2 per-
cent to 42.0 percent and their share of total development assistance resources
drop from 3.1 percent to 2.8 percent. These trends apply not only to aid-
recipient countries as a whole, but to the subset of least-income countries.
The observed declines in share are consistent neither with the current
emphasis on health as a priority sector in development, as evidenced by the
prominence of health concerns in the Millennium Development Goals, nor
with growing awareness of links between health and poverty. The declines
lend strength to concerns, voiced by groups such as the WHO Commission
on Macroeconomics and Health, regarding the insufficiency of international
support for health. They also raise issues about how effectively health assis-
tance is addressing the needs of the poor. Finally, concentrating assistance
on HIV/AIDS, however laudable the intent, carries with it the danger of
lopsided, distorted health-sector development.
The answer to the second question is that the most commonly cited
prioritization tool, the burden of disease as measured in disability-adjusted
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life years, is insufficient to explain observed priorities. Previous research on
infectious diseases has concluded that factors apart from the burden of dis-
ease play a role in determining how development assistance is allocated.
Such factors, it has been argued, include the existence of cost-effective in-
terventions, the characteristics of the victims, the presence of a global ad-
vocacy community, the inability of countries to cope on their own, and the
possibility of catastrophic national and international consequences if reme-
dial steps are not taken. I have extended and strengthened these assertions
by concluding that they apply to all disease categories, not just infectious
diseases. HIV/AIDS stands out for the large allocation of resources it re-
ceives relative to its contribution to the total burden of disease; so too, though
less dramatically, does reproductive and maternal health. Disease catego-
ries receiving less support than might be expected on the basis of their con-
tribution to the burden of disease are injuries and nutritional disorders.
These results suggest the need for efforts to devise explicit priority-
setting frameworks in which the burden of disease is only one factor among
many. Ongoing work by the Global Forum for Health Research (2004) pro-
vides a model for such approaches, although this work is limited to priority
setting in health research and development.
In making a first systematic attempt to compare aid allocations to low-
income countries’ health priorities as expressed in their poverty-reduction
strategies, I have arrived at an ambiguous answer to the third question,
namely, if development assistance allocations and country priorities do cor-
respond, the correspondence is not plainly evident. I detected no clear rela-
tionship between priorities expressed in poverty-reduction strategies and
the composition of development assistance. Methodological problems may
be to blame—for example, the index I have devised may not measure pri-
orities per se but rather how well these priorities have been translated into
the framework of poverty-reduction strategies. In this case, however, I would
expect the index to be related to the share of development assistance allo-
cated to general health policy, administration, and management. I found
only slim evidence of this relationship. Whatever the explanation, I con-
clude that the absence of a clear relationship between how health is treated
in the preparation of poverty-reduction strategies and the composition of
development assistance should signal to policymakers that there is room
for improvement in the process of preparing such strategies, in the alloca-
tion of development assistance, or both.
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Heimenz of the Centre are gratefully acknowl-
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1 For example, following a $750 million
start-up grant from the Bill and Melinda Gates
Foundation, the Global Alliance for Vaccines
and Immunization has raised $577 million in
bilateral donor support but only $5 million in
private non-philanthropy-sector grants (Glo-
bal Alliance for Vaccines and Immunization
2005). Out of $35.4 million disbursed by Roll
Back Malaria in 2002, $25.7 million was fi-
nanced by traditional donors and $8.7 million
by WHO (Roll Back Malaria 2003). Out of
$340 million raised by the International AIDS
Vaccine Initiative through the end of 2003, vir-
tually all apart from a $100 million start-up
grant from the Gates Foundation came from
bilateral donors and multilateral institutions
(Skolnick et al. 2003). Out of $5,706 million
pledged through 2008 to the Global Fund to
Fight AIDS, Tuberculosis, and Malaria, only
$154 million comes from foundations (again,
mostly the Gates Foundation), private firms,
and individuals (the Global Fund to Fight
AIDS, Tuberculosis, and Malaria 2004). In
short, these new actors are simply replicating
the existing structure of aid flows.
2 These are the country- and project-level
data in the “All details” (5-digit category) da-
tabase. Available online at «http://www1.oecd.
org/scripts/cde/members/CRSAuthenticate.
asp».
3 If one took account of the fact that many
reproductive health and family planning
projects contain HIV/AIDS components, the
decline in share would be more pronounced.
4 Comprehensive global estimates of dis-
ability-adjusted life years by disease category
were first prepared by the WHO Global Bur-
den of Disease Project as background research
for the 1993 World Development Report (Murray
and Lopez 1996). DALYs were proposed, and
have been broadly accepted, as one of the most
important tools for health policy priority set-
ting (World Bank forthcoming 2006). In re-
cent years, WHO produced updated burden-
of-disease estimates for 2000, 2001, and 2002
(Mathers et al. 2002). A minor inconvenience
is that the regions used by WHO for aggregat-
ing country-level DALY estimates are not com-
parable to the regions used by the Develop-
ment Assistance Committee. However, the
WHO estimates for 2001 have been re-aggre-
gated according to World Bank income regions
(which are comparable to Development Assis-
tance Committee regions) by the Disease Con-
trol Priorities Project alluded to above. These
estimates, to be published next year in the sec-
ond edition of Disease Control Priorities in Devel-
oping Countries (World Bank forthcoming
2006), provide the basis for the discussion in
this section. The data have been posted online
(with accompanying methodological informa-
tion) at «http://www.fic.nih.gov/dcpp/gbd.
html».
5 A detailed search of project titles, as op-
posed to 5-digit CRS codes, would turn up a
handful of projects in these areas; however,
for practical purposes, we may assume that de-
velopment assistance directly targeted at non-
communicable diseases and injuries was zero
or close to it.
6 The slope of the trend line in Figure 1 is
admittedly sensitive to whether my imputa-
tion assumption is accurate, especially as it ap-
plies to noncommunicable diseases. If devel-
opment assistance for general health is
disproportionately benefiting the well-to-do
through public health systems insufficiently
attuned to the needs of the poor (an argument
made by many), then the trend line might be
steeper. This is because the rich live longer and
are more likely to suffer from chronic and de-
generative conditions; hence, the data point
corresponding to noncommunicable diseases
would shift vertically upward. However, real-
locating general health assistance to noncom-
municable diseases would mean reallocating
it from other disease conditions. It is likely that
HIV/AIDS, which places heavy demands on
hospital systems, would still be an outlier on
the high side of the new trend line. It is diffi-
cult to make similar speculations about other
disease conditions.
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7 The targets associated with the health-
related Millennium Development Goals are to
(i) reduce child mortality by two-thirds be-
tween 1990 and 2015, (ii) reduce the mater-
nal mortality ratio by three-quarters between
1990 and 2015, (iii) halt and begin to reverse
the spread of AIDS by 2015, (iv) halt and be-
gin to reverse the incidence of malaria and
other major diseases by 2015. In the area of
References
Atkinson, Tony 2003. Innovative Sources for Development Finance—Global Public Economics. Paper
prepared for ABCDE-Europe 2003.
Christiansen, K. and Inge Hovland. 2003. “The PRSP initiative: Multilateral policy change and
the role of research,” Overseas Development Institute Working Paper 216(August). London:
ODI.
Development Assistance Committee-UNAIDS. 2004. Analysis of Aid in Support of HIV/AIDS Con-
trol, 2000–2002. Paris: OECD.
Devaradjan, Shantayanan, Margaret Miller, and Eric V. Swanson. 2002. “Goals for develop-
ment: History, prospects, and costs,” World Bank Policy Research Working Paper No. 2819.
Washington, DC: World Bank. Available online at «http://ssrn.com/abstract=636102».
Global Alliance for Vaccines and Immunization. 2005. “Donors to the Global Alliance for Vac-
cines and Immunization and The Vaccine Fund,” fact sheet published online at «www.
vaccinealliance.org».
Global Forum for Health Research. 2004. The 10/90 Report on Health Research 2003–2004. Geneva:
Global Forum for Health Research. Available online at «www. globalforum.org».
Global Fund to Fight AIDS, Tuberculosis, and Malaria. 2004. Progress Reports on financial dis-
bursements, resource mobilization, and resource needs, 31 December. Posted online at
«http://www.theglobalfund.org/en/about/publications/».
Lomborg, Bjørn (ed.). 2004. Global Crises, Global Solutions. Cambridge: Cambridge University Press.
MacKellar, L. 2005. “Priorities in global assistance for health, AIDS, and population,” OECD
Development Centre Working Paper No. 244. Paris: OECD.
Maizels, A. and M. K. Nissanke 1984. “Motivations for aid in developing countries,” World De-
velopment 12(9): 879–900.
Mason, J. B., P. Musgrove, and J.-P. Habicht. 2003. “At least one-third of poor countries’ dis-
ease burden is due to malnutrition,” Disease Control Priorities Project Working Paper No.1
Bethesda, MD: Fogarty International Center, National Institutes of Health.
Mathers, Colin D. et al. 2002. Global Burden of Disease 2000: Version 2 Methods and Results. Global
Programme on Evidence for Health Policy Discussion Paper No. 50. Geneva: World Health
Organization.
Murray, C. and A. Lopez 1996. Global Burden of Disease, 1990. Cambridge, MA: Harvard Univer-
sity Press.
Organization for Economic Co-operation and Development (OECD). 2001. 2000 Development
Co-operation Report. Paris: OECD.
Reisen, H. 2004. “Innovative approaches to funding the Millennium Development Goals,” OECD
Development Centre Policy Brief No. 24. Paris: OECD.
Roberts, John. 2003. “Poverty reduction outcomes in education and health public expenditure
and aid,” Overseas Development Institute Working Paper 210 (April). London: ODI.
Roll Back Malaria. 2003. Final Report of the External Evaluation of Roll Back Malaria. Pub-
lished online at «http://www.rbm.who.int/cmc_upload/0/000/015/905/ee_toc.htm».
health, the associated target is to (v) provide,
in cooperation with pharmaceutical compa-
nies, access to affordable essential drugs in de-
veloping countries. General Assembly, A/55/
L.2, 18 September 2000.
8 Available online, together with back-
ground documentation, at «http://www.who.
int/hdp/database/».
312 P R I O R I T I E S  I N  G L O B A L  A S S I S T A N C E
Sagasti, Francisco and Keith Bezanson. 2001. “Financing and providing global public goods,”
Development Financing 2000 Study 2001:2. Stockholm: Swedish Ministry for Foreign Affairs.
Sandler, T. and D. Arce. 2001. “A conceptual framework for understanding global and transnational
goods for health,” Committee on Macroeconomics and Health Working Paper WG2:1. Geneva:
WHO. Available online at «http://www.cmhealth.org/docs/wg2_paper1.pdf».
Shiffman, Jeremy. 2004. Donor Funding Priorities for Communicable Disease Control in Developing
Countries. Unpublished working paper, Department of Public Administration, Maxwell
School of Public Administration, Syracuse University, Syracuse, New York.
Skolnik, Richard et al. 2003. Independent Evaluation of the International AIDS Vaccine Initiative (IAVI).
New York: IAVI.
Stansfield, Sally K., Malayah Harper, Geofrey Lamb, and Julian Lob-Levyt. 2001. “Innovative fi-
nancing of international public goods for health,” Committee for Macroeconomics and Health Work-
ing Paper No. WG2:22. Geneva: World Health Organization. Available online at «http://www.
cmhealth.org/docs/wg2_paper22.pdf».
United Nations. 2001. “Report of the High Level Panel on Financing for Development.” Avail-
able online at «http://www.un.org/reports/financing/report_full.htm».
United Nations Development Program. 2003. Human Development Report 2003. New York: UNDP.
World Bank. nd. Getting Serious about Meeting the Millennium Development Goals. Washington, DC:
World Bank.
———. 2002 (September 18). Better Measuring, Monitoring, and Managing for Development Results.
Washington, DC: World Bank.
———. 2003 (13 September). “Supporting sound policies with adequate and appropriate fi-
nancing,” report prepared for the Sept. 22, 2003 meeting of the Development Commit-
tee. Document No. DC2003-0016. Washington, DC: World Bank
———. 2006. Disease Control Priorities in Developing Countries. Second edition. Forthcoming
World Health Organization Commission on Macroeconomics and Health (Jeffrey D. Sachs, Chair).
2001. Macroeconomics and Health: Investing in Health For Economic Development. WHO: Geneva.
